MedPath

Randomized Trial Investigating Melatonin Supplementation vs Placebo on Sleep Disturbance Following Total Joint Arthroplasty

Not Applicable
Conditions
Sleep Disturbance
Total Joint Arthroplasty
Interventions
Drug: Placebo
Registration Number
NCT04590742
Lead Sponsor
Rothman Institute Orthopaedics
Brief Summary

The purpose of this study is to determine whether melatonin when used as a supplement after surgery improves sleep following total joint arthroplasty

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
154
Inclusion Criteria
  1. Patients who undergo unilateral primary total joint arthroplasty
  2. Patient willing and able to complete postoperative surveys
Exclusion Criteria
  1. Patients who undergo revision total joint arthroplasty
  2. Patients who undergo bilateral total joint arthroplasty
  3. Patients currently taking melatonin supplementation
  4. Patient has history of substance abuse (drug or alcohol)
  5. Patient is a workman's comp patient or patient has current litigation pending
  6. Patient has an allergy to melatonin
  7. Patient has a history of delirium/psychiatric/depression/on antidepressants
  8. Patient has a history of insomnia/ on sleep aid medication
  9. Anyone on warfarin
  10. Sleep apnea
  11. Patient discharged to SNF or rehab
  12. Patients who have inflammatory conditions
  13. Shift work or night work

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 1PlaceboPlacebo Tablet
Group 2melatonin 6mgMelatonin (6mg)
Primary Outcome Measures
NameTimeMethod
Patient Sleep Quality6 weeks

Patients quality of sleep will be analyzed by having them answer a sleep quality index (PSQI) questionnaires

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rothman Orthopaedic Institute

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath